Supreme Court temporarily lifts mail ban on abortion pill mifepristone
In this photo illustration, A packet of Mifepristone is seen at Wyoming’s last abortion clinic, Wellspring Center March 10, 2025
Read More
pill
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t
Read More
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the
Read More
FDA says Novo Nordisk’s TV ad for obesity pill includes ‘false or misleading’ claims
The Food and Drug Administration said Novo Nordisk’s TV advertisement for its newly launched Wegovy pill for obesity included “false
Read More
Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey |
Read More
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.Â
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of
Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of
Read More
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials,
Read More